Allocation of Proceeds from the Public Offering to Human Resources and Research and Development
First written in FY2022. 1 of 3 entries say "Raised", first in FY2024-Q1. Latest entry: FY2024-H1.
0 other companies' latest entry also says "Advanced".
- FY2024-H1AdvancedAnnual report
「At a board meeting held on 13 May 2024, the Company resolved to issue new shares through a private placement to Dai Nippon Printing Co.,Ltd., and all payments were completed on 26 June 2024. This mainly comprised ¥999,815 thousand in proceeds from the share issuance and ¥41,196 thousand in repayments of long-term borrowings.」
The private placement to Dai Nippon Printing Co.,Ltd. was completed on 26 June 2024, raising ¥999,815 thousand. The financing under the previously disclosed use-of-proceeds plan was executed. - FY2024-Q1RaisedAnnual report
「Specific uses Amount (¥ million) Scheduled spending period 1. Costs of expanding resources to accelerate business development, including joint development with DNP 454 July 2024–December 2026 2. R&D expenses in the XR field 147 July 2024–December 2026 3. Advertising expenses 101 July 2024–December 2026 4. Funds for future M&A and capital and business alliances 287 July 2024–December 2026 Total 989 —」
Plan to allocate ¥454 million to resource expansion including joint development with DNP, ¥147 million to R&D, ¥101 million to advertising and ¥287 million to future M&A and capital and business alliances. The scope expanded from the previous focus on personnel, recruitment and R&D expenses. - FY2022First statedAnnual report
「The proceeds raised through the Company’s public offering are planned to be allocated to personnel expenses, recruitment expenses and R&D expenses.」
Plan to allocate public offering proceeds to personnel, recruitment and R&D expenses. Proceeds from the 2022 share issuance were ¥878,640 thousand.